AstraZeneca invests $3.5B in US R&D and manufacturing

AstraZeneca announced $3.5 billion of capital investment in the United States to expand its research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating over a thousand jobs, with projects in Massachusetts, Maryland, and Texas.

“Our multibillion dollar investment reflects the attractiveness of the business environment together with the quality of talent and innovation capabilities here in the United States.”astrazeneca.com

• 1 source
• astrazeneca.comAstraZeneca invests $3.5 billion in R&D and manufacturing ...Nov 12, 2024

Summarized from public sources; check the original articles before acting on it.